Advanced Search
Article Contents
ABOUT THIS ARTICLE
The Innovation Drug Discovery > Online
PERSPECTIVE   Open Access     Cite

Strategies for developing anti-Hantavirus drugs

  • 1.

    College of Chemical Engineering, State Key Laboratory of Advanced Optical Polymer and Manufacturing Technology, Qingdao Key Laboratory of Biomacromolecular Drug Discovery and Development, Qingdao University of Science and Technology, Qingdao 266061, China

  • 2.

    Institute of Frontier Chemistry, School of Chemistry and Chemical Engineering, Shandong University, Qingdao 266000, China

  • 3.

    Department of Medicinal Chemistry, State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, Shandong Basic Science Special Academic Zone (Pharmacy), School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China

More Information
The Innovation Drug Discovery  https://doi.org/10.59717/j.xinn-drugdisc.2026.100035  |  Cite this article
    • FullText(HTML)
  • 加载中
    • REFERENCES
  • [1] Afzal S., Ali L., Batool A., et al. (2023). Hantavirus: an overview and advancements in therapeutic approaches for infection. Front. Microbiol. 14:1233433. DOI:10.3389/fmicb.2023.1233433

    View in Article CrossRef Google Scholar

    [2] Wang B., Pei J., Zhang H., et al. (2022). Dihydropyridine-derived calcium channel blocker as a promising anti-hantavirus entry inhibitor. Front. Pharmacol. 13:940178. DOI:10.3389/fphar.2022.940178

    View in Article CrossRef Google Scholar

    [3] Mayor J., Engler O. and Rothenberger S. (2021). Antiviral efficacy of ribavirin and favipiravir against Hantaan virus. Microorganisms 9:1306. DOI:10.3390/microorganisms9061306

    View in Article CrossRef Google Scholar

    [4] Chung D. H., Kumarapperuma S. C., Sun Y., et al. (2008). Synthesis of 1-β-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus. Antiviral Res. 79:19−27. DOI:10.1016/j.antiviral.2008.02.003

    View in Article CrossRef Google Scholar

    [5] Ye C., Wang D., Liu H., et al. (2019). An improved enzyme-linked focus formation assay revealed baloxavir acid as a potential antiviral therapeutic against Hantavirus infection. Front. Pharmacol. 10:1203. DOI:10.3389/fphar.2019.01203

    View in Article CrossRef Google Scholar

    [6] Xing Y., Zhao Y., Luo L., et al. (2026). Direct targeting of the nucleocapsid protein by morin inhibits Hantaan virus infection. Biochem. Biophys. Res. Commun. 795:153081. DOI:10.1016/j.bbrc.2025.153081

    View in Article CrossRef Google Scholar

    [7] Gorbunova E. E., Gavrilovskaya I. N., Pepini T., et al. (2011). VEGFR2 and Src kinase inhibitors suppress Andes virus-induced endothelial cell permeability. J. Virol. 85:2296−2303. DOI:10.1128/JVI.02319-10

    View in Article CrossRef Google Scholar

    [8] Bird B. H., Shrivastava-Ranjan P., Dodd K. A., et al. (2016). Effect of vandetanib on Andes virus survival in the hamster model of Hantavirus pulmonary syndrome. Antiviral Res. 132:66−69. DOI:10.1016/j.antiviral.2016.05.014

    View in Article CrossRef Google Scholar

    [9] Dang Y., Wang Y., Wei J., et al. (2024). 25-Hydroxycholesterol inhibits Hantavirus infection by reprogramming cholesterol metabolism. Free Radic. Biol. Med. 224:232−245. DOI:10.1016/j.freeradbiomed.2024.08.029

    View in Article CrossRef Google Scholar

    [10] Garrido J. L., Prescott J., Calvo M., et al. (2018). Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo. Sci. Transl. Med. 10:eaat6420. DOI:10.1126/scitranslmed.aat6420

    View in Article CrossRef Google Scholar

    • Cited by

  • Cite this article:

    Du S., Hu X., Li J., et al. (2026). Strategies for developing anti-Hantavirus drugs. The Innovation Drug Discovery 1:100035. https://doi.org/10.59717/j.xinn-drugdisc.2026.100035
    Du S., Hu X., Li J., et al. (2026). Strategies for developing anti-Hantavirus drugs. The Innovation Drug Discovery 1:100035. https://doi.org/10.59717/j.xinn-drugdisc.2026.100035

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

PDF
Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(128) PDF downloads(29)

Relative Articles

Cited by

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return

    {{newsColumn.name}}

    {{newsColumn.name}}

    Stay connected

    {{newsColumn.name}}

    Published articles are licensed under CC BY with copyright retained by the authors.
    All contents on this site: Copyright © 2026 INNOVATION PRESS. All rights are reserved.